{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:29:26Z","timestamp":1787318966369,"version":"build-2736575974"},"reference-count":145,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:00:00Z","timestamp":1760313600000},"content-version":"vor","delay-in-days":285,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100015659","name":"Southern Federal University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment and Research Communications"],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/j.ctarc.2025.101019","type":"journal-article","created":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T17:13:57Z","timestamp":1760807637000},"page":"101019","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Harnessing nanotechnology for efficient delivery of indole-based drugs in cancer treatment"],"prefix":"10.1016","volume":"45","author":[{"given":"Nutan","family":"Shukla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ratnesh","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aayushi","family":"Chanderiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol Y.","family":"C\u00e1rdenas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizaveta","family":"Mukhanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Soldatov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Belbekhouche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctarc.2025.101019_bib0001","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ctarc.2025.101019_bib0002","doi-asserted-by":"crossref","first-page":"538","DOI":"10.7150\/jca.2.538","article-title":"Malignant melanoma in the elderly: different regional disease and poorer prognosis","volume":"2","author":"Macdonald","year":"2011","journal-title":"J. Cancer"},{"key":"10.1016\/j.ctarc.2025.101019_bib0003","first-page":"252","article-title":"Cancer treatment and survivorship statistics, 2014","volume":"64","author":"DeSantis","year":"2014","journal-title":"CA Cancer J. Clin"},{"key":"10.1016\/j.ctarc.2025.101019_bib0004","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s10593-012-0960-z","article-title":"Heterocycles in drugs and drug discovery","volume":"48","author":"Gomtsyan","year":"2012","journal-title":"Chem. Heterocycl. Compd."},{"key":"10.1016\/j.ctarc.2025.101019_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12951-018-0392-8","article-title":"Nano based drug delivery systems: recent developments and future prospects","volume":"16","author":"Patra","year":"2018","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.ctarc.2025.101019_bib0006","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1049\/iet-nbt.2014.0062","article-title":"Nanobiotechnology and its applications in drug delivery system: a review","volume":"9","author":"Khan","year":"2015","journal-title":"IET Nanobiotechnol."},{"key":"10.1016\/j.ctarc.2025.101019_bib0007","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jmgm.2004.03.016","article-title":"Selection of heterocycles for drug design","volume":"23","author":"Broughton","year":"2004","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.ctarc.2025.101019_bib0008","article-title":"Synthesis and antimicrobial activities of some new heterocyclic compounds based on 6-chloropyridazine-3(2H)-thione","volume":"2013","author":"El-salam","year":"2013","journal-title":"J. Chem."},{"key":"10.1016\/j.ctarc.2025.101019_bib0009","doi-asserted-by":"crossref","first-page":"832","DOI":"10.3390\/molecules18010832","article-title":"Synthesis and antibacterial evaluation of novel heterocyclic compounds containing a sulfonamido moiety","volume":"18","author":"Azab","year":"2013","journal-title":"Molecules"},{"key":"10.1016\/j.ctarc.2025.101019_bib0010","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1002\/ardp.201300183","article-title":"Synthesis, antibacterial, and antiviral evaluation of new heterocycles containing the pyridine moiety","volume":"346","author":"Salem","year":"2013","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.ctarc.2025.101019_bib0011","doi-asserted-by":"crossref","first-page":"3687","DOI":"10.1021\/jm4016284","article-title":"Design, synthesis, and structure\u2014Activity relationship studies of novel fused heterocycles-linked triazoles with good activity and water solubility","volume":"57","author":"Cao","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ctarc.2025.101019_bib0012","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.arabjc.2012.12.041","article-title":"Synthesis, anti-inflammatory, analgesic and anticonvulsant activities of some new 4,6-dimethoxy-5-(heterocycles)benzofuran starting from naturally occurring visnagin","volume":"7","author":"El-Sawy","year":"2013","journal-title":"Arab. J. Chem."},{"key":"10.1016\/j.ctarc.2025.101019_bib0013","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ejmech.2014.04.026","article-title":"Synthesis, characterization and anti-proliferative activity of heterocyclic hypervalent organo antimony compounds","volume":"79","author":"Chen","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ctarc.2025.101019_bib0014","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.arabjc.2012.04.003","article-title":"Synthesis, antimicrobial and anticancer activities of some new N-methyl sulphonyl and N-benzenesulphonyl-3-indolyl heterocycles: 1st cancer update","volume":"6","author":"El-Sawy","year":"2013","journal-title":"Arab. J. Chem."},{"key":"10.1016\/j.ctarc.2025.101019_bib0015","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/1752-153X-7-112","article-title":"Synthesis, reactions and biological activity of some new bis-heterocyclic ring compounds containing sulphur atom","volume":"7","author":"Mabkhot","year":"2013","journal-title":"Chem. Cent. J."},{"key":"10.1016\/j.ctarc.2025.101019_bib0016","first-page":"1","article-title":"Heterocyclic compounds: an introduction","volume":"1","author":"Alv\u00e1rez-Builla","year":"2011","journal-title":"Mod. Heterocycl. Chem."},{"key":"10.1016\/j.ctarc.2025.101019_bib0017","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejmech.2018.02.065","article-title":"Indole in the target-based design of anticancer agents: a versatile scaffold with diverse mechanisms","volume":"150","author":"Dadashpour","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ctarc.2025.101019_bib0018","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/nnano.2007.387","article-title":"Nanocarrier as an emerging platform for cancer therapy","volume":"2","author":"Peer","year":"2007","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.ctarc.2025.101019_bib0019","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1158\/0008-5472.CAN-08-3786","article-title":"Is anticancer drug development heading in the right direction?","volume":"69","author":"Hambley","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.ctarc.2025.101019_bib0020","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1158\/1541-7786.MCR-09-0220","article-title":"Sunitinib induces apoptosis and growth arrest of medulloblastoma tumor cells by inhibiting STAT3 and AKT signaling pathways","volume":"8","author":"Yang","year":"2010","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.ctarc.2025.101019_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103021","article-title":"Medicinal chemistry of Indole derivatives: current to future therapeutic prospectives","volume":"89","author":"Kumari","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ctarc.2025.101019_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2022.116614","article-title":"Structural modification aimed for improving solubility of lead compounds in early phase drug discovery","volume":"56","author":"Das","year":"2022","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ctarc.2025.101019_bib0023","doi-asserted-by":"crossref","first-page":"6538","DOI":"10.3390\/ijms22126538","article-title":"Nanotechnology of tyrosine kinase inhibitors in cancer therapy: a perspective","volume":"22","author":"Russo","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ctarc.2025.101019_bib0024","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1021\/jm201384j","article-title":"Nucleoside, nucleotide, and non-nucleoside inhibitors of hepatitis C virus NS5B RNA-dependent RNA-polymerase","volume":"55","author":"Sofia","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ctarc.2025.101019_bib0025","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/7081_2010_52","article-title":"Electrophilic substitution reactions of indoles","volume":"26","author":"Sundberg","year":"2010","journal-title":"Heterocyclic Scaffolds II: Reactions and Applications of Indoles"},{"key":"10.1016\/j.ctarc.2025.101019_bib0026","doi-asserted-by":"crossref","first-page":"9088","DOI":"10.1021\/jo0614339","article-title":"Nucleophilic reactivities of indoles","volume":"71","author":"Lakhdar","year":"2006","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.ctarc.2025.101019_bib0027","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.bioorg.2017.06.006","article-title":"Auspicious role of the steroidal heterocyclic derivatives as a platform for anti-cancer drugs","volume":"73","author":"Tantawy","year":"2017","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ctarc.2025.101019_bib0028","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1021\/acs.chemrev.5b00346","article-title":"Degradable controlled-release polymers and polymeric nanoparticles: mechanisms of controlling drug release","volume":"116","author":"Kamaly","year":"2016","journal-title":"Chem. Rev."},{"issue":"1","key":"10.1016\/j.ctarc.2025.101019_bib0029","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/10245330500276592","article-title":"A phase II study of thalidomide and vinblastine for palliative patients with Hodgkin's lymphoma","volume":"11","author":"Kuruvilla","year":"2006","journal-title":"Hematology"},{"key":"10.1016\/j.ctarc.2025.101019_bib0030","doi-asserted-by":"crossref","first-page":"200","DOI":"10.7326\/0003-4819-102-2-200","article-title":"Treatment of Kaposi\u2019s sarcoma and thrombocytopenia with vincristine in patients with the Acquired Immunodeficiency syndrome","volume":"102","author":"Mintzer","year":"1985","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ctarc.2025.101019_bib0031","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1002\/1097-0142(19840615)53:12<2601::AID-CNCR2820531205>3.0.CO;2-D","article-title":"Treatment of advanced Non-Hodgkin\u2019s lymphoma with vincristine infusion","volume":"53","author":"Jackson","year":"1984","journal-title":"Cancer"},{"key":"10.1016\/j.ctarc.2025.101019_bib0032","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.3390\/molecules20022973","article-title":"Indole alkaloids from Catharanthus roseus: bioproduction and their effect on Human health","volume":"20","author":"Almagro","year":"2015","journal-title":"Molecules"},{"key":"10.1016\/j.ctarc.2025.101019_bib0033","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3892\/ijmm.2012.1167","article-title":"Vincristine induces cell cycle arrest and apoptosis in SH-SY5Y Human neuroblastoma cells","volume":"31","author":"Tu","year":"2013","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.ctarc.2025.101019_bib0034","doi-asserted-by":"crossref","first-page":"652","DOI":"10.2174\/138945010791170923","article-title":"Anticancer properties of indole compounds: mechanism of apoptosis induction and role in chemotherapy","volume":"11","author":"Ahmad","year":"2010","journal-title":"Curr. Drug Targets"},{"issue":"12","key":"10.1016\/j.ctarc.2025.101019_bib0035","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.3390\/biom12121843","article-title":"Recent advances of tubulin inhibitors targeting the colchicine binding site for cancer therapy","volume":"12","author":"Hawash","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.ctarc.2025.101019_bib0036","article-title":"Innovative nanomaterials for cancer diagnosis, imaging, and therapy: drug deliveryapplications","volume":"82","author":"Pourmadadi","year":"2023","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ctarc.2025.101019_bib0041","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/ng1531","article-title":"Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of Human cancer","volume":"37","author":"Fraga","year":"2005","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ctarc.2025.101019_bib0042","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.4161\/15592294.2014.983367","article-title":"Dysregulated class I histone deacetylases are indicators of poor prognosis in multiple myeloma","volume":"9","author":"Mithraprabhu","year":"2014","journal-title":"Epigenetics"},{"key":"10.1016\/j.ctarc.2025.101019_bib0043","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s40265-015-0388-8","article-title":"Panobinostat: first Global approval","volume":"75","author":"Garnock-Jones","year":"2015","journal-title":"Drugs"},{"key":"10.1016\/j.ctarc.2025.101019_bib0044","doi-asserted-by":"crossref","first-page":"10636","DOI":"10.1021\/acsnano.8b06104","article-title":"Stimuli-responsive nano-architecture drug-delivery systems to solid tumor micromilieu: past, present, and future perspectives","volume":"12","author":"El-Sawy","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.ctarc.2025.101019_bib0045","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1159\/000508529","article-title":"Phase II, multicenter, single-srm, open-label study to evaluate the efficacy and safety of Panobinostat in combination with Bortezomib and Dexamethasone in Japanese patients with relapsed or relapsed-and-refractory multiple myeloma","volume":"144","author":"Suzuki","year":"2021","journal-title":"Acta Haematol."},{"key":"10.1016\/j.ctarc.2025.101019_bib0046","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s11060-016-2059-3","article-title":"Phase I trial of panobinostat and fractionated stereotactic re-irradiation therapy for recurrent high grade gliomas","volume":"127","author":"Shi","year":"2016","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.ctarc.2025.101019_bib0047","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0168-9525(00)02021-7","article-title":"RTK mutations and Human syndromes: when good receptors turn bad","volume":"16","author":"Robertson","year":"2000","journal-title":"Trends Genet."},{"key":"10.1016\/j.ctarc.2025.101019_bib0048","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1124\/jpet.105.084145","article-title":"Role of tyrosine kinase inhibitors in cancer therapy","volume":"315","author":"Arora","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ctarc.2025.101019_bib0049","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/bs.acr.2018.02.003","article-title":"Acquired resistance to drugs targeting tyrosine kinases","volume":"138","author":"Rosenzweig","year":"2018","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/j.ctarc.2025.101019_bib0050","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12943-018-0801-5","article-title":"Advances in studies of tyrosine kinase inhibitors and their acquired resistance","volume":"17","author":"Jiao","year":"2018","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ctarc.2025.101019_bib0051","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/nrd2380","article-title":"Molecular basis for Sunitinib efficacy and future clinical development","volume":"6","author":"Faivre","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ctarc.2025.101019_bib0052","doi-asserted-by":"crossref","first-page":"5495","DOI":"10.2147\/OTT.S112242","article-title":"The antiangiogenic effects and beyond","volume":"9","author":"Hao","year":"2016","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.ctarc.2025.101019_bib0053a","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejps.2016.05.025","article-title":"Indoles\u2014A promising scaffold for drug development","volume":"91","author":"Sravanthi","year":"2016","journal-title":"Eur. J. Pharm. Sci."},{"issue":"183","key":"10.1016\/j.ctarc.2025.101019_bib0053b","article-title":"Synthesis and photodynamic properties of pyrazole-indole hybrids in the human skin melanoma cell line G361","author":"Varvuolyt\u0117","year":"2020","journal-title":"Dye. Pigment"},{"issue":"46","key":"10.1016\/j.ctarc.2025.101019_bib0141","doi-asserted-by":"crossref","first-page":"32045","DOI":"10.1021\/acsnano.4c10381","article-title":"The extracellular matrix limits nanoparticle diffusion and cellular uptake in a TissueSpecific manner","volume":"18","author":"Cahn","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.ctarc.2025.101019_bib0054","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/tcr.202100010","article-title":"Recent advances in functionalization of pyrroles and their translational potential","volume":"21","author":"Hunjan","year":"2021","journal-title":"Chem. Rec."},{"key":"10.1016\/j.ctarc.2025.101019_bib0055","doi-asserted-by":"crossref","first-page":"14046","DOI":"10.1021\/acs.jmedchem.1c01215","article-title":"Bioisosteres of the phenyl ring: recent strategic applications in lead optimization and drug design","volume":"64","author":"Subbaiah","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ctarc.2025.101019_bib0056","doi-asserted-by":"crossref","first-page":"12290","DOI":"10.1021\/acs.jmedchem.0c00530","article-title":"Amide bond bioisosteres: strategies, synthesis, and successes","volume":"63","author":"Kumari","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ctarc.2025.101019_bib0057","doi-asserted-by":"crossref","first-page":"9608","DOI":"10.1002\/anie.200901843","article-title":"Catalytic functionalization of indoles in a new dimension","volume":"48","author":"Bandini","year":"2009","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ctarc.2025.101019_bib0058","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1039\/C4CS00253A","article-title":"Metal-mediated post-Ugi transformations for the construction of diverse heterocyclic scaffolds","volume":"44","author":"Sharma","year":"2015","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.ctarc.2025.101019_bib0059","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ejmech.2017.10.065","article-title":"Therapeutic potential of songorine, a diterpenoid alkaloid of the genus Aconitum","volume":"153","author":"Khan","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ctarc.2025.101019_bib0060a","doi-asserted-by":"crossref","first-page":"9608","DOI":"10.1002\/anie.200901843","article-title":"Catalytic functionalization of indoles in a new dimension","volume":"48","author":"Bandini","year":"2009","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ctarc.2025.101019_bib0060b","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.eurpolymj.2015.07.047","article-title":"Electrosprayed poly (butylene succinate) microspheres loaded with indole derivatives: a system with anticancer activity","volume":"71","author":"Murase","year":"2015","journal-title":"Eur. Polym. J."},{"key":"10.1016\/j.ctarc.2025.101019_bib0060c","doi-asserted-by":"crossref","DOI":"10.1016\/j.enzmictec.2021.109889","article-title":"Hyaluronic acid-coated chitosan nanoparticles as carrier for the enzyme\/prodrug complex based on horseradish peroxidase\/indole-3-acetic acid: characterization and potential therapeutic for bladder cancer cells","volume":"150","author":"Pereira","year":"2021","journal-title":"Enzym. Microb. Technol."},{"key":"10.1016\/j.ctarc.2025.101019_bib0060d","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2021.112089","article-title":"Chitosan and chitosan\/PEG nanoparticles loaded with indole-3-carbinol: characterization, computational study and potential effect on human bladder cancer cells","volume":"124","author":"Melo","year":"2021","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.ctarc.2025.101019_bib0060e","doi-asserted-by":"crossref","first-page":"37905","DOI":"10.1039\/C8RA07060A","article-title":"Facile synthesis of indole heterocyclic compounds based micellar nano anti-cancer drugs","volume":"8","author":"Ali","year":"2018","journal-title":"RSC Adv."},{"key":"10.1016\/j.ctarc.2025.101019_bib0060f","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119738","article-title":"Enhanced drug retention, sustained release, and anti-cancer potential of curcumin and indole-curcumin analog-loaded polysorbate 80-stabilizied PLGA nanoparticles in colon cancer cell line SW480","volume":"588","author":"Sufi","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ctarc.2025.101019_bib0060g","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfa.2024.134794","article-title":"Antiproliferative activity in metastatic breast cancer cells of nanoparticles containing a novel indole-thiazole derivative","volume":"700","author":"Soares","year":"2024","journal-title":"Colloids Surf. A Physicochem. Eng. Asp."},{"key":"10.1016\/j.ctarc.2025.101019_bib0060h","doi-asserted-by":"crossref","first-page":"6404","DOI":"10.1039\/D0BM00970A","article-title":"A cascade dual-targeted nanocarrier for enhanced alectinib delivery to ALK-positive lung cancer","volume":"8","author":"Zeng","year":"2020","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.ctarc.2025.101019_bib0062","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/med.21377","article-title":"Strategies for the optimization of natural leads to anticancer drugs or drug candidates","volume":"36","author":"Xiao","year":"2016","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ctarc.2025.101019_bib0063","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119738","article-title":"Enhanced drug retention, sustained release, and anti-cancer potential of curcumin and indole-curcumin analog-loaded polysorbate 80-stabilizied PLGA nanoparticles in colon cancer cell line SW480","volume":"588","author":"Sufi","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ctarc.2025.101019_bib0064","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1111\/jphp.13098","article-title":"An overview of active and passive targeting strategies to improve the nanocarriers efficiency to tumour sites","volume":"71","author":"Attia","year":"2019","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ctarc.2025.101019_bib0065","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.3390\/molecules28062587","article-title":"Target-based anticancer indole derivatives for the development of anti-glioblastoma agents","volume":"28","author":"Salerno","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.ctarc.2025.101019_bib0066","doi-asserted-by":"crossref","first-page":"540","DOI":"10.2174\/1389557518666181116120145","article-title":"Molecular targets, anti-cancer properties and potency of synthetic indole-3-carbinol derivatives","volume":"19","author":"Karimabad","year":"2019","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.ctarc.2025.101019_bib0067","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1517\/14728222.2013.834890","article-title":"Molecular mechanisms of the pro-apoptotic actions of melatonin in cancer: a review","volume":"17","author":"Bizzarri","year":"2013","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.ctarc.2025.101019_bib0068","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2174\/1574892811666161003112119","article-title":"Kinase inhibitor indole derivatives as anticancer agents: a patent review","volume":"12","author":"Rathi","year":"2017","journal-title":"Recent Pat. Anti-Cancer Drug Discov."},{"key":"10.1016\/j.ctarc.2025.101019_bib0069","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.immuni.2022.01.006","article-title":"Tryptophan-derived microbial metabolites activate the aryl hydrocarbon receptor in tumor-associated macrophages to suppress anti-tumor immunity","volume":"55","author":"Hezaveh","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.ctarc.2025.101019_bib0070","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.imlet.2007.06.001","article-title":"Tumor immune escape mediated by indoleamine 2, 3-dioxygenase","volume":"111","author":"Zamanakou","year":"2007","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.ctarc.2025.101019_bib0071","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2174\/1574892811666161003112119","article-title":"Kinase inhibitor indole derivatives as anticancer agents: a patent review","volume":"12","author":"Rathi","year":"2017","journal-title":"Recent Pat. Anti-Cancer Drug Discov."},{"key":"10.1016\/j.ctarc.2025.101019_bib0072","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.3390\/ma13143197","article-title":"Dendropanax morbifera extract-mediated ZnO nanoparticles loaded with indole-3-carbinol for enhancement of anticancer efficacy in the A549 human lung carcinoma cell line","volume":"13","author":"Rupa","year":"2020","journal-title":"Materials (Basel)"},{"key":"10.1016\/j.ctarc.2025.101019_bib0075","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/s44222-023-00067-z","article-title":"Biomolecular sensors for advanced physiological monitoring","volume":"1","author":"Flynn","year":"2023","journal-title":"Nat. Rev. Bioeng."},{"key":"10.1016\/j.ctarc.2025.101019_bib0084","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.3390\/pharmaceutics15071815","article-title":"Indole antitumor agents in nanotechnology formulations: an overview","volume":"15","author":"Russo","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ctarc.2025.101019_bib0085","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/nature05569","article-title":"Total synthesis of marine natural products without using protecting groups","volume":"446","author":"Baran","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.ctarc.2025.101019_bib0086","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1021\/cr040639b","article-title":"Synthesis and functionalization of indoles through palladium-catalyzed reactions","volume":"105","author":"Cacchi","year":"2005","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ctarc.2025.101019_bib0073","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.120953","article-title":"2, 2-Bis (hydroxymethyl) propionic acid based cyclic carbonate monomers and their (co) polymers as advanced materials for biomedical applications","volume":"275","author":"Ansari","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.ctarc.2025.101019_bib0074","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1002\/anie.200903924","article-title":"Thiol\u2013ene click chemistry","volume":"49","author":"Hoyle","year":"2010","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ctarc.2025.101019_bib0087","doi-asserted-by":"crossref","first-page":"7021","DOI":"10.1039\/C6CS00898D","article-title":"Supramolecular chemotherapy based on host\u2013guest molecular recognition: a novel strategy in the battle against cancer with a bright future","volume":"46","author":"Zhou","year":"2017","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.ctarc.2025.101019_bib0088","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.2174\/1381612826666200313172207","article-title":"Optimization and characterization of aqueous micellar formulations for ocular delivery of an antifungal drug, posaconazole","volume":"26","author":"Durgun","year":"2020","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ctarc.2025.101019_bib0089","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jpba.2014.02.022","article-title":"Analytical techniques for characterization of cyclodextrin complexes in aqueous solution: a review","volume":"101","author":"Mura","year":"2014","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ctarc.2025.101019_bib0090","doi-asserted-by":"crossref","first-page":"11909","DOI":"10.1007\/s10973-022-11383-8","article-title":"Interactions in dopamine and indole loaded thermosensitive hydrogels seen by high sensitivity microDSC","volume":"147","author":"Bul\u00e1tk\u00f3","year":"2022","journal-title":"Implic. Drug Deliv. J. Therm. Anal. Calorim."},{"key":"10.1016\/j.ctarc.2025.101019_bib0076","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.3390\/pharmaceutics15071815","article-title":"Indole antitumor agents in nanotechnology formulations: an overview","volume":"15","author":"Russo","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ctarc.2025.101019_bib0077","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0065-2318(08)60167-5","article-title":"Inclusion complexes of the cyclomalto-oligosaccharides (cyclodextrins)","volume":"46","author":"Clarke","year":"1988","journal-title":"Advances in Carbohydrate Chemistry and Biochemistry"},{"key":"10.1016\/j.ctarc.2025.101019_bib0078","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1039\/D0PY01558J","article-title":"Helical polymer self-assembly and chiral nanostructure formation","volume":"12","author":"Scanga","year":"2021","journal-title":"Polym. Chem."},{"key":"10.1016\/j.ctarc.2025.101019_bib0079","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0008-6215(02)00049-6","article-title":"Structural and physicochemical characterization of the inclusion complexes of cyclomaltooligosaccharides (cyclodextrins) with melatonin","volume":"337","author":"Bongiorno","year":"2002","journal-title":"Carbohydr. Res."},{"key":"10.1016\/j.ctarc.2025.101019_bib0080","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.7150\/thno.31653","article-title":"Host-guest chemistry in supramolecular theranostics","volume":"9","author":"Yu","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.ctarc.2025.101019_bib0081","doi-asserted-by":"crossref","first-page":"13517","DOI":"10.1021\/ie402360f","article-title":"Modification strategies for carbon nanotubes as a drug delivery system","volume":"52","author":"Liu","year":"2013","journal-title":"Ind. Eng. Chem. Res."},{"key":"10.1016\/j.ctarc.2025.101019_bib0082","doi-asserted-by":"crossref","first-page":"7021","DOI":"10.1039\/C6CS00898D","article-title":"Supramolecular chemotherapy based on host\u2013guest molecular recognition: a novel strategy in the battle against cancer with a bright future","volume":"46","author":"Zhou","year":"2017","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.ctarc.2025.101019_bib0083","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.3390\/polym15051123","article-title":"Polymeric nanoparticles for delivery of natural bioactive agents: recent advances and challenges","volume":"15","author":"Elmowafy","year":"2023","journal-title":"Polymers (Basel)"},{"key":"10.1016\/j.ctarc.2025.101019_bib0091","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.2147\/IJN.S60206","article-title":"Near-infrared fluorescent probes in cancer imaging and therapy: an emerging field","volume":"9","author":"Yi","year":"2014","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ctarc.2025.101019_bib0092","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/S1470-2045(09)70240-2","article-title":"Resistance to targeted therapy in renal-cell carcinoma","volume":"10","author":"Rini","year":"2009","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ctarc.2025.101019_bib0093","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1007\/s00280-011-1798-2","article-title":"Tolerability and pharmacokinetic profile of a Sunitinib powder formulation in pediatric patients with refractory solid tumors: a children\u2019s oncology Group study","volume":"69","author":"DuBois","year":"2012","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.ctarc.2025.101019_bib0094","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00280-019-03814-5","article-title":"Sunitinib in pediatric patients with advanced gastrointestinal stromal tumor: results from a phase I\/II trial","volume":"84","author":"Verschuur","year":"2019","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.ctarc.2025.101019_bib0095","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0092-8674(00)80108-7","article-title":"Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis","volume":"86","author":"Hanahan","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.ctarc.2025.101019_bib0096","first-page":"503","article-title":"Reducing lung function decline in patients with idiopathic pulmonary fibrosis: potential of Nintedanib","volume":"7","author":"Woodcock","year":"2013","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.ctarc.2025.101019_bib0097","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.3390\/ma13143197","article-title":"Dendropanax morbifera extract-mediated ZnO nanoparticles loaded with indole-3-carbinol for enhancement of anticancer efficacy in the A549 human lung carcinoma cell line","volume":"13","author":"Rupa","year":"2020","journal-title":"Materials (Basel)"},{"key":"10.1016\/j.ctarc.2025.101019_bib0098","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ejpb.2016.08.006","article-title":"Novel diindolylmethane derivatives based NLC formulations to improve the oral bioavailability and anticancer effects in triple negative breast cancer","volume":"108","author":"Godugu","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ctarc.2025.101019_bib0099","doi-asserted-by":"crossref","first-page":"e447","DOI":"10.1016\/S1470-2045(15)00246-6","article-title":"Treatment approaches for EGFR-inhibitor-resistant patients with non-small-cell lung cancer","volume":"16","author":"Tan","year":"2015","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ctarc.2025.101019_bib0100","doi-asserted-by":"crossref","first-page":"589","DOI":"10.7863\/ultra.14.10038","article-title":"In vitro and in vivo evaluation of targeted Sunitinib-loaded polymer microbubbles against proliferation of renal cell carcinoma","volume":"35","author":"Hu","year":"2016","journal-title":"J. Ultrasound Med."},{"key":"10.1016\/j.ctarc.2025.101019_bib0101","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1016\/j.nano.2018.06.011","article-title":"Near-infrared light-activated IR780-loaded liposomes for anti-tumor angiogenesis and photothermal therapy","volume":"14","author":"Yang","year":"2018","journal-title":"Nanomedicine"},{"key":"10.1016\/j.ctarc.2025.101019_bib0102","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.3390\/pharmaceutics15071815","article-title":"Indole antitumor agents in nanotechnology formulations: an overview","volume":"15","author":"Russo","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ctarc.2025.101019_bib0103","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.msec.2018.06.019","article-title":"PH-controlled sunitinib anticancer release from magnetic chitosan nanoparticles crosslinked with \u03ba-carrageenan","volume":"91","author":"Karimi","year":"2018","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.ctarc.2025.101019_bib0104","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.msec.2018.06.019","article-title":"PH-controlled sunitinib anticancer release from magnetic chitosan nanoparticles crosslinked with \u03ba-carrageenan","volume":"91","author":"Karimi","year":"2018","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.ctarc.2025.101019_bib0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2021.117719","article-title":"Highly efficient Sunitinib release from PH-responsive MHPMC@Chitosan core-shell nanoparticles","volume":"258","author":"Jafari","year":"2021","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ctarc.2025.101019_bib0106","first-page":"2856","article-title":"Bioavailability enhancement of vitamin E TPGS liposomes of Nintedanib esylate: formulation optimization, cytotoxicity and pharmacokinetic studies. Drug deliv","volume":"12","author":"Kala","year":"2022","journal-title":"Transl. Res."},{"key":"10.1016\/j.ctarc.2025.101019_bib0107","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2021.105715","article-title":"Enhanced oral bioavailability of Nintedanib esylate with nanostructured lipid carriers by lymphatic targeting: in Vitro, cell line and in vivo evaluation","volume":"159","author":"Patel","year":"2021","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ctarc.2025.101019_bib0108","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0168-3659(02)00137-2","article-title":"Characterization of the initial burst release of a model peptide from poly (d,l-lactide-co-glycolide) microspheres","volume":"82","author":"Wang","year":"2002","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ctarc.2025.101019_bib0109","article-title":"Acquired resistance to third-generation EGFR-TKIs and emerging next-generation EGFR inhibitors","volume":"2","author":"Du","year":"2021","journal-title":"Innovation"},{"key":"10.1016\/j.ctarc.2025.101019_bib0110","doi-asserted-by":"crossref","first-page":"939","DOI":"10.3390\/pharmaceutics12100939","article-title":"Development of liposomal vesicles for osimertinib delivery to egfr mutation\u2014Positive lung cancer cells","volume":"12","author":"Skupin-Mrugalska","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ctarc.2025.101019_bib0111","doi-asserted-by":"crossref","first-page":"5491","DOI":"10.2147\/IJN.S258699","article-title":"Enhanced anti-brain metastasis from non-small cell lung cancer of Osimertinib and Doxorubicin Co-delivery targeted nanocarrier","volume":"15","author":"Wang","year":"2020","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ctarc.2025.101019_bib0112","doi-asserted-by":"crossref","first-page":"4567","DOI":"10.2147\/OTT.S174548","article-title":"Profile of alectinib for the treatment of ALK-positive non-small cell lung cancer (NSCLC): patient selection and perspectives","volume":"12","author":"Karachaliou","year":"2019","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.ctarc.2025.101019_bib0113","doi-asserted-by":"crossref","first-page":"5171","DOI":"10.1158\/1078-0432.CCR-16-1293","article-title":"FDA approval: alectinib for the treatment of metastatic, ALK-positive non-small cell lung cancer following Crizotinib","volume":"22","author":"Larkins","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ctarc.2025.101019_bib0114","doi-asserted-by":"crossref","first-page":"4953","DOI":"10.1039\/C9TB01159E","article-title":"The programmed site-specific delivery of the angiostatin Sunitinib and chemotherapeutic Paclitaxel for highly efficient tumor treatment","volume":"7","author":"He","year":"2019","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.ctarc.2025.101019_bib0115","doi-asserted-by":"crossref","first-page":"5042","DOI":"10.1021\/acsabm.9b00727","article-title":"Incorporation of ZnO\/bioactive glass nanoparticles into alginate\/chitosan composite hydrogels for wound closure","volume":"2","author":"Zhu","year":"2019","journal-title":"ACS Appl. Bio Mater."},{"key":"10.1016\/j.ctarc.2025.101019_bib0116","doi-asserted-by":"crossref","first-page":"11476","DOI":"10.1021\/acs.chemrev.7b00194","article-title":"Form follows function: nanoparticle shape and its implications for nanomedicine","volume":"117","author":"Kinnear","year":"2017","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ctarc.2025.101019_bib0117","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1039\/b517779k","article-title":"Nanomaterials under high-pressure","volume":"35","author":"San-Miguel","year":"2006","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.ctarc.2025.101019_bib0118","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119738","article-title":"Enhanced drug retention, sustained release, and anti-cancer potential of curcumin and indole-curcumin analog-loaded polysorbate 80-stabilizied PLGA nanoparticles in colon cancer cell line SW480","volume":"588","author":"Sufi","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ctarc.2025.101019_bib0119","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jmst.2023.09.026","article-title":"Cross-linked lipoic acid nanoparticles with indole-3-methanol loading for the PTEN-mediated TNBC treatment","volume":"181","author":"Xiao","year":"2024","journal-title":"J. Mater. Sci. Technol."},{"key":"10.1016\/j.ctarc.2025.101019_bib0120","article-title":"PLGA-based dual-loaded nanoformulation of DIM and TMZ-an advanced clinical strategy for brain cancer treatment in a combinatorial approach","author":"Sarkar","year":"2023","journal-title":"bioRxiv"},{"key":"10.1016\/j.ctarc.2025.101019_bib0121","first-page":"118","article-title":"Folic acid-conjugated liposomal vincristine for multidrug resistant cancer therapy","volume":"8","author":"Wang","year":"2013","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.ctarc.2025.101019_bib0122","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s12282-019-00950-x","article-title":"3, 3\u2032-Diindolylmethane-encapsulated chitosan nanoparticles accelerate molecular events during chemical carcinogen-induced mammary cancer in Sprague Dawley rats","volume":"26","author":"Isabella","year":"2019","journal-title":"Breast Cancer"},{"key":"10.1016\/j.ctarc.2025.101019_bib0123","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1504\/IJBNN.2014.065464","article-title":"Bio-based calcium carbonate (CaCO3) nanoparticles for drug delivery applications","volume":"3","author":"Render","year":"2014","journal-title":"Int. J. Biomed. Nanosci. Nanotechnol."},{"key":"10.1016\/j.ctarc.2025.101019_bib0124","doi-asserted-by":"crossref","first-page":"10292","DOI":"10.1021\/acsnano.1c11560","article-title":"Bioorthogonal catalysis for treatment of solid tumors using thermostable, self-assembling, single enzyme nanoparticles and natural product conversion with indole-3-acetic acid","volume":"16","author":"Sadeghi","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.ctarc.2025.101019_bib0125","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1021\/np0000623","article-title":"Antineoplastic agents 440. Asymmetric synthesis and evaluation of the combretastatin A-1 SAR probes (1 S, 2 S)-and (1 R, 2 R)-1, 2-dihydroxy-1-(2\u2032, 3\u2032-dihydroxy-4\u2032-methoxyphenyl)-2-(3\u2033, 4\u2033, 5\u2033-trimethoxyphenyl)-ethane","volume":"63","author":"Pettit","year":"2000","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.ctarc.2025.101019_bib0126","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1046\/j.1439-0507.2002.00722.x","article-title":"Antifungal and cancer cell growth inhibitory activities of 1-(3\u2032, 4\u2032, 5\u2032-trimethoxyphenyl)-2-nitro-ethylene","volume":"45","author":"Pettit","year":"2002","journal-title":"Mycoses"},{"key":"10.1016\/j.ctarc.2025.101019_bib0128","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1016\/j.bmcl.2013.01.045","article-title":"Design, synthesis and aromatase inhibitory activities of novel indole-imidazole derivatives","volume":"23","author":"Wang","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ctarc.2025.101019_bib0127","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1021\/jo01078a019","article-title":"Potential cancerocidal agents. I. The aromatic system of podophyllotoxin (Part A)","volume":"25","author":"Pettit","year":"1960","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.ctarc.2025.101019_bib0129","doi-asserted-by":"crossref","first-page":"3892","DOI":"10.1021\/acs.molpharmaceut.8b00359","article-title":"An indole\u2013chalcone inhibits multidrug-resistant cancer cell growth by targeting microtubules","volume":"15","author":"Cong","year":"2018","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ctarc.2025.101019_bib0130","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.bioorg.2018.12.015","article-title":"Synthesis, molecular properties prediction and biological evaluation of indole-vinyl sulfone derivatives as novel tubulin polymerization inhibitors targeting the colchicine binding site","volume":"85","author":"Li","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ctarc.2025.101019_bib0131","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1093\/nsr\/nwx028","article-title":"Recent progress in organocatalytic asymmetric total syntheses of complex indole alkaloids","volume":"4","author":"Song","year":"2017","journal-title":"Natl. Sci. Rev."},{"key":"10.1016\/j.ctarc.2025.101019_bib0132","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1016\/j.bmcl.2012.01.130","article-title":"N-1 and C-3 substituted indole Schiff bases as selective COX-2 inhibitors: synthesis and biological evaluation","volume":"22","author":"Kaur","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ctarc.2025.101019_bib0133","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1016\/j.bmcl.2012.01.130","article-title":"N-1 and C-3 substituted indole Schiff bases as selective COX-2 inhibitors: synthesis and biological evaluation","volume":"22","author":"Kaur","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ctarc.2025.101019_bib0134","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1021\/acsmedchemlett.9b00557","article-title":"Dalla Via, L. Synthesis, antiproliferative effect, and topoisomerase ii inhibitory activity of 3-methyl-2-phenyl-1 H-indoles","volume":"11","author":"Zidar","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ctarc.2025.101019_bib0135","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.drup.2007.03.003","article-title":"Overcoming resistance to molecularly targeted anticancer therapies: rational drug combinations based on EGFR and MAPK inhibition for solid tumours and haematologic malignancies","volume":"10","author":"Tortora","year":"2007","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.ctarc.2025.101019_bib0136","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.3390\/ijms19082232","article-title":"Synthesis, biological evaluation and molecular docking of novel indole-aminoquinazoline hybrids for anticancer properties","volume":"19","author":"Mphahlele","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ctarc.2025.101019_bib0137","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1248\/bpb.32.1609","article-title":"Experimental photodynamic therapy for liver cancer cell-implanted nude mice by an indole-3-acetic acid and intense pulsed light combination","volume":"32","author":"Park","year":"2009","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.ctarc.2025.101019_bib0138","doi-asserted-by":"crossref","first-page":"4606","DOI":"10.1021\/acs.nanolett.1c00548","article-title":"Real-time imaging of hepatic inflammation using hydrogen sulfide-activatable second near-infrared luminescent nanoprobes","volume":"21","author":"Liu","year":"2021","journal-title":"Nano Lett."},{"key":"10.1016\/j.ctarc.2025.101019_bib0139","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1016\/j.apsb.2021.08.021","article-title":"Tumor-targeted\/reduction-triggered composite multifunctional nanoparticles for breast cancer chemo-photothermal combinational therapy","volume":"12","author":"Yang","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"issue":"4","key":"10.1016\/j.ctarc.2025.101019_bib0140","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3390\/jmp5040029","article-title":"Oncomatrix: molecular composition and biomechanical properties of the extracellular matrix in Human tumors","volume":"5","author":"Klabukov","year":"2024","journal-title":"J. Mol. Pathol."},{"issue":"2","key":"10.1016\/j.ctarc.2025.101019_bib0142","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3390\/jpm11020088","article-title":"Harnessing extracellular matrix biology for tumor drug delivery","volume":"11","author":"Subrahmanyam","year":"2021","journal-title":"J. Pers. Med."}],"container-title":["Cancer Treatment and Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294225001558?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294225001558?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T01:06:22Z","timestamp":1773191182000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468294225001558"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":145,"alternative-id":["S2468294225001558"],"URL":"https:\/\/doi.org\/10.1016\/j.ctarc.2025.101019","relation":{},"ISSN":["2468-2942"],"issn-type":[{"value":"2468-2942","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Harnessing nanotechnology for efficient delivery of indole-based drugs in cancer treatment","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment and Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctarc.2025.101019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101019"}}